Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senate Finance Committee investigating J&J

Executive Summary

The Senate Finance Committee is seeking information from Johnson & Johnson on medical education activities the company funded for its heartburn drug Propulsid (cisapride). A July 5 letter to the company from committee Chairman Charles Grassley (R-Iowa) and Ranking Member Max Baucus (D-Mont.) cites a June New York Times article discussing promotion of Propulsid's use in children before the company ceased marketing the product in 2000. The committee asks J&J to identify specific dollar amounts for educational grants and employees responsible for those grants between 1993 and 2000...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS046062

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel